Moderna vaccine produces twice as many antibodies as Pfizer, study finds – New York Post
Moderna’s vaccine produces twice as many antibodies as the Pfizer-BioNTech vaccine, new research has revealed.
Antibody levels after the second dose of the two most popular vaccines in the US were higher in people who had the Moderna shot, according to new research published in the Journal of the American Medical Association.
In the US, more than 94 million people have had both Pfizer-BioNTech vaccines compared to 65 million who have had both Moderna shots, according to the Centers for Disease Control and Prevention.
The researchers said the difference could simply be that the second Moderna vaccine is, on average, administered one week later than the Pfizer vaccine.
The second vaccine of Moderna is typically given four weeks after the first shot, while th...